Pharmaceutical Executive-12-01-2009

Pharmaceutical Executive
Features

January 13, 2010

A new pharma consortium focuses on securing the supply chain upstream. Pharm Exec interviews Rx360 to learn more.

Pharmaceutical Executive
Features

January 06, 2010

FDA Commissioner Margaret Hamburg has a history of health advocacy and a clear mandate to transform the agency. But can she succeed where others have failed?

Pharmaceutical Executive

China's explosive growth in R&D is putting the natiion on its way to becoming the world's second-largest market by 2020

Pharmaceutical Executive
Features

December 01, 2009

As the old orthodoxy shatters, pharma must stand firm or leave the field.

Pharmaceutical Executive

Marketers will need to address not only the benefits of the therapy but also the benefits of a diagnostic assay.

Pharmaceutical Executive
Washington Report

December 01, 2009

They already dominate the pharmaceutical market, and now generics are poised to move into biologics and complex dosage forms.

Pharmaceutical Executive
Columns

December 01, 2009

Process-driven managed-care rebating programs can drive profitability

Pharmaceutical Executive
Features

December 01, 2009

Our sixth annual pipeline report details 44 drugs that industry will be talking about in 2010.

Pharmaceutical Executive
From the Editor

December 01, 2009

The fight against cancer may be the litmus test for how regulation and private investment work together to address the disease burden.